Skip to main content
. 2022 Apr 8;7:100013. doi: 10.1016/j.ajmo.2022.100013

Table 4.

Prevalence of study outcomes among patients admitted for pneumonia, according to the presence and acuity of HF

Heart Failure
Factor, No. (%) Total No Yes Acute HF Chronic HF
(N=783,702) (N=571,499) (N=212,203) (N=56,306) (N=48,188)
In hospital mortality 74,255 (9.5) 46,292 (8.1) 27,963(13.2) 7,261 (12.9) 4,588 (9.5)
Length of stay, Median[Q1, Q3] 5.0 [3.0,8.0] 5.0 [3.0,7.0] 6.0[4.0,10.0] 7.0 [4.0,11.0] 5.0 [3.0,9.0]
Cost, Median[Q1, Q3] 9003.1[5,473,16,183] 8174[5107,14423] 11708[6,992,20,816] 13893[8420, 23,934] 10130[6291,17511]
Intensive care unit 246,136 (31.4) 158,348 (27.7) 87,788(41.3) 27,298 (48.5) 16,317 (33.9)
Mechanical ventilation 119,195 (15.2) 73,739 (12.9) 45,456 (21.4) 14,730 (26.2) 7,508 (15.6)
Vasopressor 107,051 (13.7) 68,366 (12.0) 38,685 (18.2) 11,527 (20.5) 6,774 (14.1)
Inotropes / vasodilators 23,672/ 615,114(3.9) 12,918/464,391(2.8) 10,754 / 150,723(7.1) 3,744 / 37,870(9.9) 1,912 / 34,782(5.5)
Acute kidney injury 192,390 (24.5) 120,067 (21.0) 72,323 (34.1) 22,046 (39.3) 15,303 (31.8)

*P values for all outcome comparisons between HF versus no HF were < 0.001

†P-values for all comparisons between acute versus chronic HF were < 0.001

All comparisons were made using Person's chi-square test.